Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Hechanova GroupEditha R Hechanova of Hechanova & Co Inc explains the hurdles that are preventing Filipino lawmakers from legalising medical cannabis -
Sponsored by GoldenGate LawyersLinda Zhao of GoldenGate Lawyers looks at the specific guidance issued by the Supreme Court which clarifies the application of punitive damages
-
Sponsored by Januar Jahja & PartnersAndrew Diamond and Fabiola Rossy of Januar Jahja and Partners take a closer look at a recent court decision where an Indonesian theme park were ordered to remove an installation based on an iconic Los Angeles monument
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners discuss an important ruling where a discovery of evidence application played a significant role in fast-tracking a case
-
Sponsored by Tilleke & GibbinsKhin Myo Myo Aye of Tilleke & Gibbins provides an update on Myanmar’s IP department during the ‘soft-opening’ period
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Mohandas Konnanath of RNA, Technology and IP Attorneys look at Britannia and ITC’s arguments in the case which alleges conscious copying
